dwa4949

5.5 million in volume

NASDAQ:BLPH   None
Large volume today, hopefully the momentum continues tomorrow. BIIB announced that it has dosed the first patient in the phase III study — TOPAZ-1. This news is from last week on Friday.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。